Allogeneic hematopoietic stem cell transplantation for Crohn disease complicated with myelodysplastic syndrome: A case report.

Medicine
Ying ZhangXiao-Lin Guo

Abstract

Myelodysplastic syndrome (MDS) can be complicated with Crohn disease (CD). Irritable bowel disease (IBD) associated with MDS has already been reported in the past; however, hematopoietic stem cell transplantation (HSCT) is rarely performed. Herein, we report a case of CD with MDS for HSCT. A 41-year-old man was hospitalized due to abdominal pain and intermittent fever for 40 days. Two years later, he was readmitted due to abdominal pain and diarrhea with fever for 10 days. Symptoms, laboratory examinations, and imaging findings of the patient were indicative of CD complicated with MDS. An allogeneic HSCT was performed. He died of severe lung infection 125 days post-transplantation. The number of cases of CD combined with MDS remains insufficient, and no consensus opinions are available to date. Hence, HSCT is a very potential treatment method. Additional experiences are needed to determine its effectiveness.

References

Oct 15, 1992·Annals of Internal Medicine·C EngR M Stone
May 25, 1999·Inflammatory Bowel Diseases·G C HarewoodW J Sandborn
Jun 5, 2003·Transplantation·Markus DitschkowskiAhmet H Elmaagacli
Jul 20, 2006·Pediatric Hematology and Oncology·Sergio Carlos NahasVicente Odoni
Apr 7, 2007·Blood·Shahram Y KordastiGhulam J Mufti
Mar 5, 2009·British Journal of Cancer·L A AndersonE A Engels
Jun 23, 2010·American Journal of Hematology·Andrea PiccinOwen P Smith
Mar 30, 2011·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Irene BouchliouIoannis Kotsianidis
Jun 22, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sigurdur Y KristinssonLynn R Goldin

❮ Previous
Next ❯

Methods Mentioned

BETA
MDS
biopsy

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.